Overcoming AAV Innate Immunity Barriers to Further Gene Therapy Development
Time: 11:30 am
day: Post-Conference Discussion Day - Track A
Details:
- Current understanding of AAV innate immune response
- Exploring the capsid and transgene immune response
- How can we overcome innate immunity to AAV to ensure development of safer, more efficacious gene therapies?
